SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53

被引:15
|
作者
Chen, Fengjuan [1 ,2 ]
Zhang, Ka [3 ]
Huang, Yilin [4 ]
Luo, Fang [1 ]
Hu, Kunpeng [5 ]
Cai, Qingxian [1 ]
机构
[1] Third Peoples Hosp Shenzhen, Dept Hepatol, 29 Bulan Rd, Shenzhen 518112, Peoples R China
[2] Guangzhou Eighth Peoples Hosp, Dept Hepatol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Dept Rehabil, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Gen Surg, Affiliated Hosp 3, Guangzhou 510000, Peoples R China
来源
FEBS OPEN BIO | 2020年 / 10卷 / 07期
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; metastasis; p53; proliferation; SPC25; WGCNA; LIVER-DISEASE; CANCER; LOOP;
D O I
10.1002/2211-5463.12872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis and high mortality. To identify key genes associated with HCC and the underlying mechanisms, we performed weighted correlation network analysis (WGCNA) of potential key genes of HCC. We identified 17 key genes closely related to HCC by yellow module combined with PPI analysis. Verification of the role of these genes revealed that SPC25 knockdown results in a significant decrease in proliferation and metastasis of HCC cells and increased protein levels of components of the p53 pathway in vitro. In summary, we identified that SPC25 is a potential tumor-promoting factor in HCC and may act via the p53 pathway.
引用
收藏
页码:1261 / 1275
页数:15
相关论文
共 50 条
  • [41] p53 as a prognostic predictor in hepatocellular carcinoma (HCC)
    Gianni, S
    Cecchetto, A
    Altavilla, G
    Michelotto, M
    Rinaldi, M
    De Giorgio, M
    Fagiuoli, S
    Farinati, F
    JOURNAL OF HEPATOLOGY, 2003, 38 : 96 - 97
  • [42] P53 MUTATIONS MAY BE RELATED TO TUMOR INVASIVENESS OF HUMAN HEPATOCELLULAR-CARCINOMA IN CHINA
    QIN, LX
    TANG, ZY
    LIU, KD
    YE, SL
    ZHOU, G
    ONCOLOGY REPORTS, 1995, 2 (06) : 1175 - 1179
  • [43] High glucose may promote the proliferation and metastasis of hepatocellular carcinoma via E2F1/RRBP1 pathway
    He, Yuan
    Huang, Shuai
    Cheng, Ting
    Wang, Yao
    Zhou, Sai-Jun
    Zhang, Ya-Min
    Yu, Pei
    LIFE SCIENCES, 2020, 252
  • [44] miR-3168 promotes hepatocellular carcinoma progression via downregulating p53
    Lu, Tingting
    Han, Tao
    Zhao, Mingfang
    CARCINOGENESIS, 2022, 43 (10) : 956 - 968
  • [45] p53 may positively regulate hepatocyte proliferation in rats
    Inoue, Y
    Tomiya, T
    Yanase, M
    Arai, M
    Ikeda, H
    Tejima, K
    Ogata, I
    Kimura, S
    Omata, M
    Fujiwara, K
    HEPATOLOGY, 2002, 36 (02) : 336 - 344
  • [46] MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma
    Yu, Youtao
    Zhang, Yubao
    Hu, Jianran
    Zhang, Hao
    Wang, Shan
    Han, Fang
    Yue, Lei
    Qu, Youpeng
    Zhang, Yao
    Liang, Hongjian
    Nie, Huan
    Li, Yu
    CANCER SCIENCE, 2012, 103 (04) : 716 - 722
  • [47] High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma
    Anzola, M
    Saiz, A
    Cuevas, N
    Lopez-Martinez, M
    Martinez de Pancorbo, MA
    Burgos, JJ
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (06) : 502 - 510
  • [48] Dehydrocostus lactone inhibits the proliferation and metastasis of hepatocellular carcinoma cells via modulating p53-p21-CDK2 signaling pathway
    Tian, Yingying
    Ma, Beibei
    Zhao, Xinyue
    Tian, Shiqiu
    Li, Yilin
    Pei, Hailuan
    Yu, Shangyue
    Liu, Chuang
    Lin, Zhaozhou
    Zuo, Zeping
    Wang, Zhibin
    ARABIAN JOURNAL OF CHEMISTRY, 2023, 16 (08)
  • [49] Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway
    Shang, Qi-Xin
    Zhang, Han -Lu
    Cheng, Ya-Ping
    Lu, Han
    Yuan, Yong
    Chen, Long-Qi
    Ji, Ai -Fang
    HELIYON, 2024, 10 (01)
  • [50] p16 and p53 gene alterations in hepatocellular carcinoma
    Estalilla, OE
    King, TC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 842 - 842